2 min listen
Moving On from AAV with Poseida Therapeutics' CEO, Mark Gergen
Moving On from AAV with Poseida Therapeutics' CEO, Mark Gergen
ratings:
Length:
28 minutes
Released:
Jun 23, 2022
Format:
Podcast episode
Description
Poseida Therapeutics is a broad platform technology company led by CEO, Mark Gergen. During this episode, Gergen explains how and why the company is moving away from AAV delivery in favor of nanoparticle delivery. He shares some of the biggest hurdles the CGT sector faces when it comes to the development of off-the-shelf therapies as well as the manufacturing challenges Poseida has had to overcome and how they did it.
Released:
Jun 23, 2022
Format:
Podcast episode
Titles in the series (76)
Introducing Cell & Gene: The Podcast by Cell & Gene: The Podcast